⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Jennifer AparicioM.D.

Medical Oncology · Boston, MA 02114

NPI: 1588701783

Share:

31

🟠 Elevated

Risk Flags

Very high opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

278

Total Claims

$273K

Drug Cost

77

Beneficiaries

$3,541

Cost/Patient

Risk Score Breakdown 31/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Long-acting opioid rate+8
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 3,372 Medical Oncology providers

+527%

Opioid rate vs peers

36.7% vs 5.9% avg

-71%

Cost per patient vs peers

$3,541 vs $12K avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 527% above the average for Medical Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

36.7%

Opioid Rate

102

Opioid Claims

$8,319

Opioid Cost

50.0%

Long-Acting Rate

This provider's opioid prescribing rate of 36.7% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 247 claims · $12K

Patient Profile

70

Avg Age

73%

Female

2.20

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About